Radiation dose estimates in humans for (11)C-acetate whole-body PET.

scientific article published in July 2004

Radiation dose estimates in humans for (11)C-acetate whole-body PET. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID15235071

P2093author name stringMichael E Phelps
David B Stout
Magnus Dahlbom
Nagichettiar Satyamurthy
Jorge R Barrio
Marc A Seltzer
Richard Sparks
Shamim A Jahan
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)1233-1236
P577publication date2004-07-01
P1433published inThe Journal of Nuclear MedicineQ7743608
P1476titleRadiation dose estimates in humans for (11)C-acetate whole-body PET.
P478volume45

Reverse relations

cites work (P2860)
Q3720947911C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.
Q3809844118F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients
Q3721451318F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
Q90309705Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET
Q33523536Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.
Q35556123Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review
Q60305515Current Imaging Techniques for Lymph Node Staging in Prostate Cancer: A Review
Q40094312Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study
Q39512219Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
Q35633633Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Q40364894Future direction of renal positron emission tomography
Q43253704Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation
Q34619649Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model
Q36129937Molecular imaging of prostate cancer: PET radiotracers
Q47100803Normal Uptake of 11C-Acetate in Pancreas, Liver, Spleen, and Suprarenal Gland in PET.
Q38606252Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.
Q35288176PET Imaging of Prostate Cancer Using C-Acetate
Q39003086PET Tracers Beyond FDG in Prostate Cancer.
Q46704395PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective
Q36308766PET/CT in prostate cancer: non-choline radiopharmaceuticals
Q37518179Pharmacokinetics, metabolism, biodistribution, radiation dosimetry, and toxicology of (18)F-fluoroacetate ((18)F-FACE) in non-human primates
Q33890153Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
Q37127700Prediction of all-cause death using (11)C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction
Q34448553Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline
Q34062324Prostate-specific antigen and prostate-specific antigen velocity as threshold indicators in 11C-acetate PET/CTAC scanning for prostate cancer recurrence
Q38715665Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Q61449123Radiation dosimetry of [Ga]PSMA-11 in low-risk prostate cancer patients
Q37217782Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies
Q38058333The clinical use of PET with (11)C-acetate.
Q36113718The metabolic fate of acetate in cancer
Q37094838Visualizing pancreatic beta-cell mass with [11C]DTBZ.
Q53501793[1-(11)C]acetate uptake is not increased in renal cell carcinoma.
Q39985717[11C] acetoacetate utilization by breast and prostate tumors: a PET and biodistribution study in mice.
Q53527477[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

Search more.